Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

510 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunology of hepatitis C virus infections.
Spaan M, Janssen HL, Boonstra A. Spaan M, et al. Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):391-400. doi: 10.1016/j.bpg.2012.09.005. Best Pract Res Clin Gastroenterol. 2012. PMID: 23199499 Review.
Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.
Janssen HL, Berk L, Schalm SW, Heijtink RA, Hess G, Rossol S, Meyer zum Buschenfelde KH, Chamuleau RA, Jansen PL, Reesink HW, et al. Janssen HL, et al. Gut. 1992 Aug;33(8):1094-8. doi: 10.1136/gut.33.8.1094. Gut. 1992. PMID: 1398234 Free PMC article. Clinical Trial.
Suicide associated with alfa-interferon therapy for chronic viral hepatitis.
Janssen HL, Brouwer JT, van der Mast RC, Schalm SW. Janssen HL, et al. J Hepatol. 1994 Aug;21(2):241-3. doi: 10.1016/s0168-8278(05)80402-7. J Hepatol. 1994. PMID: 7989716
Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep).
Janssen HL, Brouwer JT, Nevens F, Sanchez-Tapias JM, Craxi A, Hadziyannis S. Janssen HL, et al. BMJ. 1993 Jan 9;306(6870):107-8. doi: 10.1136/bmj.306.6870.107. BMJ. 1993. PMID: 8435602 Free PMC article. No abstract available.
Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.
Janssen HL, Schalm SW, Berk L, de Man RA, Heijtink RA. Janssen HL, et al. J Hepatol. 1993;17 Suppl 3:S47-51. doi: 10.1016/s0168-8278(05)80423-4. J Hepatol. 1993. PMID: 8509639
Quantitative measurement of HBeAg in chronic hepatitis B: a comparison between a radioimmunoassay, a fluorescence ELISA and a chemiluminescence ELISA.
Heijtink RA, Snobl J, Kruining J, Kerkhof-Los C, de Man RA, Janssen HL, Schalm SW. Heijtink RA, et al. J Med Virol. 1995 Nov;47(3):245-50. doi: 10.1002/jmv.1890470310. J Med Virol. 1995. PMID: 8551276
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).
Janssen HL, Gerken G, CarreƱo V, Marcellin P, Naoumov NV, Craxi A, Ring-Larsen H, Kitis G, van Hattum J, de Vries RA, Michielsen PP, ten Kate FJ, Hop WC, Heijtink RA, Honkoop P, Schalm SW. Janssen HL, et al. Hepatology. 1999 Jul;30(1):238-43. doi: 10.1002/hep.510300113. Hepatology. 1999. PMID: 10385662 Clinical Trial.
[Chronic hepatitis-b-virus infections: new options for antiviral therapy].
de Man RA, Honkoop P, Janssen HL, Schalm SW. de Man RA, et al. Ned Tijdschr Geneeskd. 1999 Sep 11;143(37):1857-61. Ned Tijdschr Geneeskd. 1999. PMID: 10526598 Review. Dutch.
Acute hepatitis C infection: an indication for alfa interferon therapy?
van der Vlies CH, Tang TJ, Niesters HG, Zondervan PE, Janssen HL, de Man RA. van der Vlies CH, et al. Neth J Med. 2000 Jul;57(1):30-3. doi: 10.1016/s0300-2977(00)00027-9. Neth J Med. 2000. PMID: 10863000 No abstract available.
510 results
Jump to page